Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

CCN3 / NOV / IGFBP9 Antikörper (Antigen Affinity Purified)

Produkt-Information von CCN3 / NOV / IGFBP9 Antikörper

Immunogen

Recombinant Human CCN3 / NOV / IGFBP9 protein (Catalog#10264-H08B)

Antibody Type Rabbit Polyclonal Antibody ( Antibody Purification Platform )
Ig Type

Rabbit IgG

Formulation 0.2 μm filtered solution in PBS with 5% trehalose
Preparation

Produced in rabbits immunized with purified, recombinant Human CCN3 / NOV / IGFBP9 (rh CCN3 / NOV / IGFBP9; Catalog#10264-H08B; NP_002505.1; Met 1-Met 357). CCN3 / NOV / IGFBP9 specific IgG was purified by Human CCN3 / NOV / IGFBP9 affinity chromatography.

Usage Guide von CCN3 / NOV / IGFBP9 Antikörper

Specificity

Human CCN3 / NOV / IGFBP9

Immunochemistry

IHC-P: 2-5 μg/mL

NOV-brain(from-donor-1) immunohistochemistry

Immunochemical staining of human NOV in human brain with rabbit polyclonal antibody (2 μg/mL, formalin-fixed paraffin embedded sections).
The left panel: tissue incubated with primary antibody;
The right panel: tissue incubated with the mixture of primary antibody and antigen (recombinant protein).

NOV-brain(from-donor-2) immunohistochemistry    NOV-brain(from-donor-3) immunohistochemistry

Immunochemical staining of human NOV in human brain (from 2 donors) with rabbit polyclonal antibody (2 μg/mL, formalin-fixed paraffin embedded sections).

Western blot This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human NOV in WB.Using a DAB detection system, the detection limit for Human NOV is approximately 0.5 ng/lane under non-reducing conditions and 2 ng/lane under reducing conditions.
Direct ELISA This antibody can be used at 0.1-0.2 μg/mL with the appropriate secondary reagents to detect Human NOV. The detection limit for Human NOV is approximately 0.00245 ng/well.
Storage This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃.Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

Verwandte Produkte & Themen von CCN3 / NOV / IGFBP9 Antikörper

Related Areas:

Cancer>>Angiogenesis>>ECM Molecules in Angiogenesis>>CCN3/NOV/IGFBP9

Cancer>>Growth Factor & Receptor>>IGF System>>CCN3/NOV/IGFBP9

Cancer>>Growth Factor & Receptor>>Other>>CCN3/NOV/IGFBP9

Immunology>>Adhesion Molecule>>Extracellular Matrix Molecule>>Extracellular Matrix Protein>>CCN3/NOV/IGFBP9

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
CCN3/NOV/IGFBP9 Human CCN3/NOV/IGFBP9 Protein, Recombinant 10264-H08B
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human 
CCN3/NOV/IGFBP9
WB, ELISA CCN3/NOV/IGFBP9 Antibody, Mouse Mab 10264-MM05
Human 
CCN3/NOV/IGFBP9
WB, ELISA CCN3 / NOV (IGFBP9) Antibody 10264-R130
Human 
CCN3/NOV/IGFBP9
WB, ELISA Rabbit Polyclonal Antibody 10264-RP01
Human 
CCN3/NOV/IGFBP9
WB, ELISA, IHC-P CCN3 / NOV / IGFBP9 Antibody (Antigen Affinity Purified) 10264-RP02

Hintergrund von CCN3 / NOV / IGFBP9 Antikörper

Protein NOV homolog, also known as Nephroblastoma-overexpressed gene protein homolog, NOV, and CCN3, is secreted protein which belongs to theCCN family. CCN3 expression was observed in a broad variety of tissues from the early stage of development. It contains oneCTCK (C-terminal cystine knot-like) domain, oneIGFBP N-terminal domain, oneTSP type-1 domain, and oneVWFC domain. CCN3, a founding member of the CCN family of growth regulators, was linked with hematology in 2003 when it was detected in human serum. CCN3 acts through the core stem cell signalling pathways including Notch and Bone Morphogenic Protein, connecting CCN3 with the modulation of self-renewal and maturation of a number of cell lineages including hematopoietic, osteogenic and chondrogenic. Altered CCN3 expression is associated with numerous solid tumors including glioblastoma, melanoma, adrenocortical tumours, prostate cancer and bone malignancies including osteosarcoma. CCN3 may affect the extracellular environment of the niche for hematopoietic stem cells. CCN3 has emerged as a key player in stem cell regulation, hematopoiesis and a crucial component within the bone marrow microenvironment.

References

  1. Lombet, A.et al., 2003,Cell Commun Signal. 1 (1): 1.
  2. Katsube, K.et al., 2009, J Cell Commun Signal. 3 (2): 135-45.
  3. McCallum,L. et al., 2009, Blood Rev. 23 (2): 79-85.
  4. McCallum, LJ. et al., 2009, Cell Commun Signal. 3 (2): 115-24.

Sino Biological Inc. liefert CCN3 / NOV / IGFBP9 Antikörper (Antigen Affinity Purified) mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über CCN3 / NOV / IGFBP9 Antikörper (Antigen Affinity Purified) lesen Sie bitte: http://www.sinobiological.com/CCN3-NOV-IGFBP9-Antibody-g-8790.html

Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post